Top 10 most significant DEGs. by Foluwasomi A. Oyefeso (15999113)

List of the proteins that increased or decreased significantly with the progression of liver fibrosis. by Kumiko Shirai (13014884)

“…<p>List of the proteins that increased or decreased significantly with the progression of liver fibrosis.…”

Carbon emission factors for primary carbon sources. by Lingzhi Tan (19146572)

Subjects:

The expression of miR-122 is decreased as liver fibrosis progressed. by Young Chang (3666829)

The number of gauging cross-sections where a statistically significant decreasing trend was identified. by Krzysztof Kochanek (835532)

Syntrophy increases significantly in size-reduced metabolisms when transport of all primary carbon sources is guaranteed. by Eric Libby (241589)

Top 20 genes with significantly decreased abundance in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

Degeneration Saline group presented with significant decreased final weight in relation to other groups. by Flavia Gomes Velasque Gama (21175112)

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

After moderate and severe TBI, PWI revealed CBF was significantly decreased in the ipsilateral cortex and hippocampus at several time points relative to sham animals. by Juliana Sanchez-Molano (16792787)

T lymphocyte populations significantly increased in APRIL^-/-/BLyS^-/- group. by Natalie M. Bath (6316517)

Metformin decreases CRC-like organoids viability to the same extent as current chemotherapy without significant effects on WT organoids. by Silvia Cruz-Gil (7037249)

Source data for S1 Table. by Hiroko Yahara (9707647)

Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA. by Mieke L. M. Bentvelzen (21594442)

AD progression drives global perturbations in the microbiota. by Francesco Favero (236209)

FASN Expression in OA and RA–shows that FASN is also significantly downregulated in the disease groups for OA and RA, suggesting its decreased activity might influence disease mechanisms or progression. by Chang-sheng Liao (18591969)

“…<p>FASN Expression in OA and RA–shows that FASN is also significantly downregulated in the disease groups for OA and RA, suggesting its decreased activity might influence disease mechanisms or progression.…”

Decreased <i>Resf1</i> in cell lines paradoxically decreases metastatic capacity. by Megan R. Majocha (18529925)

Data sources. by Joseph Piscopo (18114905)

Definition and source of the used data. by Ya Wen (1396576)